Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)

China flag China · Delayed Price · Currency is CNY
32.37
+0.31 (0.97%)
Feb 27, 2026, 3:04 PM CST
Market Cap6.35B +140.6%
Revenue (ttm)1.45B -7.0%
Net Income108.09M +37.7%
EPS0.54 +35.9%
Shares Out196.11M
PE Ratio60.03
Forward PEn/a
Dividend0.20 (0.62%)
Ex-Dividend DateNov 24, 2025
Volume3,667,322
Average Volume4,942,645
Open32.65
Previous Close32.06
Day's Range31.82 - 32.65
52-Week Range11.44 - 68.80
Beta0.88
RSI42.41
Earnings DateApr 29, 2026

About SHE:002940

Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, cardiovascular, urinary system (nephropathy), anesthesia and pain, and anti-androgen. The company was founded in 2001 and is based in Shengzhou, China. [Read more]

Sector Healthcare
Founded 2001
Employees 1,275
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002940
Full Company Profile

Financial Performance

In 2024, SHE:002940's revenue was 1.51 billion, a decrease of -6.63% compared to the previous year's 1.62 billion. Earnings were 80.33 million, a decrease of -41.94%.

Financial Statements